Metraipolis › archive › dc_96dfadcbb5b3

Dupilumab-Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib — Europe PMC PMID:42152691

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42152691
DOI
10.1111/pde.70269
License (as archived)
solo-consultazione
Archived
2026-11-02T05:27:12.123Z
SHA-256 of the archived text
bd446ddcc0a73201ec0b602401a1b23b16fb5e2fa8a7613d923a43ac528d9a70
Stable URL of this page
https://metraipolis.com/documento/dc_96dfadcbb5b3

How to cite

Dupilumab-Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib — Europe PMC PMID:42152691 — Europe PMC (en), https://europepmc.org/article/MED/42152691 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_96dfadcbb5b3 (Metraipolis archive dc_96dfadcbb5b3, sha256 bd446ddcc0a73201ec0b602401a1b23b16fb5e2fa8a7613d923a43ac528d9a70)
BibTeX
@misc{dc96dfadcbb5b3,
  title = {Dupilumab-Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib — Europe PMC PMID:42152691},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42152691},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_96dfadcbb5b3; sha256 bd446ddcc0a73201ec0b602401a1b23b16fb5e2fa8a7613d923a43ac528d9a70},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42152691. Agents can read the archived copy with the MCP tool read_document.